Pacific Bio (PACB) Launches MagBead Station
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Join SI Premium – FREE
Pacific Biosciences of California, Inc. (Nasdaq: PACB) announced the launch of the MagBead Station for the PacBio RS, a product enhancement that delivers more high-value long reads, enables use of small sample amounts, and makes sample preparation more robust.
The MagBead Station upgrade and associated MagBead kit enable sequencing of longer templates, especially for samples that are biologically difficult to prepare. This results in more 4-10 kilobase long reads captured with each SMRT® Cell. Because the process is more robust, sequencing results have higher overall consistency. It also significantly reduces the amount of the input sample required, which can be critical for experiments when there is a small amount of useable DNA available from a sample.
The MagBead Station upgrade and associated MagBead kit enable sequencing of longer templates, especially for samples that are biologically difficult to prepare. This results in more 4-10 kilobase long reads captured with each SMRT® Cell. Because the process is more robust, sequencing results have higher overall consistency. It also significantly reduces the amount of the input sample required, which can be critical for experiments when there is a small amount of useable DNA available from a sample.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty discloses separation terms for departing accounting officer
- Royal Caribbean completes $1.25B senior unsecured notes offering
- AEVEX wins $41M U.S. government contract for one-way attack systems
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
